In contrast, the statin-modifiable pathways appear more likely to prevent ASCVD in PWH through effects on plaque stabilization, lipid lowering, and improved vascular health, which we now show may relate to statin regulation of ANGPTL3 (6). This evidence concerns the gene ANGPTL3 and atherosclerosis.